Cleared Traditional

K923276 - CAPNOMAC ULTIMA ANESTHESIA MONITOR

K923276 is the FDA 510(k) clearance for CAPNOMAC ULTIMA ANESTHESIA MONITOR by Datex Division Instrumentarium Corp.. It is a Class 2 Anesthesiology device (product code CBQ) cleared through the Traditional 510(k) pathway after a 380-day FDA review.

K923276 · Datex Division Instrumentarium Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1993
Decision
380d
Days
Class 2
Risk

K923276 is an FDA 510(k) clearance for the CAPNOMAC ULTIMA ANESTHESIA MONITOR. Classified as Analyzer, Gas, Enflurane, Gaseous-phase (anesthetic Concentration) (product code CBQ), Class II - Special Controls.

Submitted by Datex Division Instrumentarium Corp. (Helsinki, Finland, FI). The FDA issued a Cleared decision on July 21, 1993 after a review of 380 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1500 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Datex Division Instrumentarium Corp. devices

Submission Details

510(k) Number K923276 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 1992
Decision Date July 21, 1993
Days to Decision 380 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
240d slower than avg
Panel avg: 140d · This submission: 380d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CBQ Analyzer, Gas, Enflurane, Gaseous-phase (anesthetic Concentration)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBQ Analyzer, Gas, Enflurane, Gaseous-phase (anesthetic Concentration)

Devices cleared under the same product code (CBQ) and FDA review panel - the closest regulatory comparables to K923276.
OHMEDA MODEL 5330 ANESTHETIC AGENT MONITOR
K962648 · Ohmeda Medical · Jan 1997
OHMEDA MODEL 5330 ANESTHETIC MONITOR
K931439 · Ohmeda Medical · Oct 1993
DATASCOPE MULTINEX II
K926451 · Datascope Corp. · Aug 1993
DATASCOPE MULTINEX ID PLUS
K930303 · Datascope Corp. · Jun 1993
OHMEDA 5330 AGENT MONITOR
K890606 · Ohmeda Medical · Apr 1989
OHMEDA 5300 ANESTHETIC AGENT MONITOR
K861397 · Ohmeda Medical · May 1986